@article{6d9c50be3e5242e792dd925d83ab79ac,
title = "Computed tomography angiography co-registration with real-time fluoroscopy in percutaneous coronary intervention for chronic total occlusions",
keywords = "Chronic Disease, Computed Tomography Angiography, Coronary Angiography, Coronary Occlusion/diagnostic imaging, Fluoroscopy, Humans, Percutaneous Coronary Intervention, Tomography, X-Ray Computed, Treatment Outcome",
author = "Iosif Xenogiannis and Jaffer, \{Farouc A.\} and Shah, \{Alpesh R.\} and Mohamed Omer and Michael Megaly and Evangelia Vemmou and Ilias Nikolakopoulos and Rangan, \{Bavana V.\} and Santiago Garcia and Lesser, \{John R.\} and Cavalcante, \{Jo{\~a}o L.\} and Burke, \{M. Nicholas\} and Brilakis, \{Emmanouil S.\}",
note = "Funding Information: F. Jaffer reports research grants (Siemens, Canon, Shockwave), consulting (Boston Scientific, Abbott Vascular, Philips), speaker{\textquoteright}s fees (Biotronik, Siemens), equity interest (Intravascular Imaging, Inc.), and American College of Cardiology (Associate Editor, JACC Cardiovascular Imaging). In addition, F. Jaffer has an intravascular imaging-related patent. B. Rangan reports research grants from Infraredx, Inc., and The Spectranetics Corporation. S. Garcia reports grants from BSCI, and Edwards Lifesciences, and personal fees from Abbott Vascular, Medtronic and Edwards Lifesciences, outside the submitted work. J.L. Cavalcante reports being on the speaker{\textquoteright}s bureau for Siemens Healthineers. N. Burke reports being a shareholder in Egg Medical and MHI Ventures, being a speaker for Opsens Medical, and receiving consulting and speaker honoraria from Abbott Vascular and Boston Scientific. E. Brilakis reports consulting/speaker honoraria from Abbott Vascular, American Heart Association (Associate Editor, Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Elsevier, Infraredx, GE Healthcare, Medicure, Medtronic, Opsens, Siemens, and Teleflex, and being a shareholder in MHI Ventures and Cleerly Health. The other authors have no conflicts of interest to declare.",
year = "2021",
month = aug,
doi = "10.4244/EIJ-D-20-00175",
language = "English (US)",
volume = "17",
pages = "e433--e435",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "Europa Group",
number = "5",
}